Why this Houston health care co. is buying a sleep apnea co. for up to $225M
“We’re very bullish about the neuromodulation space.”
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Jack Witthaus Source Type: news
More News: Biotechnology | Brain | Health Management | Neurology | Sleep Apnea | Sleep Disorders | Sleep Medicine